Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects
Abstract Background Ototoxicity is one of the major side effects of platinum-based chemotherapy, especially cisplatin therapy. To date, no FDA approved agents to alleviate or prevent this ototoxicity are available. However, ototoxicity is generally believed to be produced by excessive generation of...
Main Authors: | Jiayi Gu, Yuming Chen, Ling Tong, Xueling Wang, Dehong Yu, Hao Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12951-020-00600-x |
Similar Items
-
Correction to: Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects
by: Jiayi Gu, et al.
Published: (2020-05-01) -
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
by: Sandeep Sheth, et al.
Published: (2017-10-01) -
Current Strategies to Combat Cisplatin-Induced Ototoxicity
by: Dehong Yu, et al.
Published: (2020-07-01) -
Sphingosine 1-Phosphate Receptor 2 Induces Otoprotective Responses to Cisplatin Treatment
by: Wei Wang, et al.
Published: (2020-01-01) -
The role of hyperbaric oxygen therapy (HOT) as an otoprotection agent against cisplatin ototoxicity Efeito otoprotetor da oxigenoterapia hiperbárica na toxicidade causada pela cisplatina
by: Camila C. Yassuda, et al.
Published: (2008-01-01)